Key Documents
Curriculum Vitae available Online
Natalie L. Rasgon
- Professor - Med Center Line, Psychiatry & Behavioral Science - Psychopharmacology
- Professor - Med Center Line (By courtesy), Obstetrics & Gynecology
Contact Information
- Clinical Offices
Psychiatry Department 401 Quarry Rd MC 5723 Stanford, CA 94305-5723 Telephone Work (650) 724-6689 Fax (650) 724-3144
- Academic Offices
Personal Information Email natalie.rasgon@stanford.eduAdministrative Contact Heather Kenna Clinical Research Manager Email hkenna@stanford.edu Tel Work (650) 724-0521Not for medical emergencies or patient use
Clinical Focus
- Psychiatry
Administrative Appointments
- Departmental Senator, Stanford School of Medicine , (2006– present )
- AdministrativePanel on Human Subjects in Medical Research, Stanford University, , (2004– present )
- Advisory Board on Women’s Health, Stanford Unviversity , (2004– present )
- Member, Scholar Universe Neuroscience , (2004– present )
- Alternate Senator, Stanford School of Medicine , (2004– 2006 )
- Co-Chair, Faculty Women’s Forum, Stanford University , (2004– present )
- Women's Cardiovascular Health Committee, Stanford Cardiovascular Institute , (2004– present )
- Medical School Admissions Panel, Stanford University , (2003– present )
- Chair, Women’s Wellness Seminars Program, Stanford University , (2003– present )
- Chair, Search Committee for the Elizabeth Blackwell Award, UCLA School of Medicine , (1999– 2003 )
- Search Committee for the Norman Cousins Psychoneuroimmunology Chair, UCLA School of Medicine , (1998– 1998 )
- UCLA Liver Transplant Committee, UCLA School of Medicine , (1997– 2002 )
- International Medical Graduates Committee, Southern California Psychiatric Society , (1993– 2001 )
Honors and Awards
- International Scientist of the Year, International Biographical Centre of Cambridge, England (2002)
- Leo G. Rigler, M.D. Award for Academic Achievement, Cedars-Sinai Medical Center (1995)
- Diploma with Highest Honors, Odessa Medical Institute (1980)
- First Prize, Student Research Work, Soviet Union Scientific Student Competition (1978)
- First Prize, Philosophy Division, Ukraine Scientific Student Competition (1977)
- First Prize, History Division, Soviet Union Scientific Student Competition (1975)
Professional Education
- UCLA Medical Center (1996) CA
- Cedars-Sinai Medical Center (1995) CA
- Harbor-UCLA Medical Center (1993) CA
- Odessa Medical Institute (1980) Russia
- PhD, Academy of Medical Sciences Pathological Physiology (1988)
- PhD, Academy of Medical Sciences Obstetrics & Gynecology (1988)
- MD, Odessa Medical Institute Diploma with Highest Honors (1980)
Web Site Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities.
- Consulting: Forest Pharmaceutical, Wyeth
Research Interests
Dr. Rasgon is a Professor in the Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology in the Stanford School of Medicine. Before joining Stanford in October 2002, Dr. Rasgon obtained an M.D. from the U.S.S.R. in 1980, a Ph.D. in Reproductive Endocrinology in 1988 from the Central Institute of Postgraduate Medical Education, and a Ph.D. in Pathological Physiology from the Central Research Institute of General Pathology & Pathological Physiology Academy of Medical Sciences, Moscow, USSR. In addition, Dr. Rasgon was an NSRA Research Fellow at the Neuropsychiatric Institute, UCLA School of Medicine from 1995-1996, an Assistant Clinical Professor, Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Neuropsychiatric Institute and Hospital, and the Director of the UCLA Menopause-Related Mood Disorders Program, UCLA Neuropsychiatric Institute and Hospital.
Dr. Rasgon has been involved in longitudinal placebo-controlled neuroendocrine studies for nearly two decades, and she has been involved in neuroendocrine and brain imaging studies of estrogen effects on depressed menopausal women for the last eight years. It should be noted that in addition to her duties as a Professor of Psychiatry and Obstetrics & Gynecology, Dr. Rasgon is also the Director of the Behavioral Neuroendocrinology Program and the Women's Wellness Program in the Department of Psychiatry. Research in the Behavioral Neuroendocrinology Program, which Dr. Rasgon founded, focuses on the interaction between reproductive hormones and brain function. Research efforts of the lab are concentrated in two areas: (1) the reproductive endocrine status of women with affective disorders, and (2) the neurobiology of the effects of hormone therapy in aging women.
Clinical Trials
- Estrogen Use in Protection from Cognitive Decline No longer recruiting
Publications
- J Psychiatr Res. 2009; (3): 341-3
- J Affect Disord. 2009; (1-2): 152-7
- J Affect Disord. 2009; (3): 170-5
- J Psychiatr Res. 2009; (8): 798-802
- Curr Diab Rep. 2009; (1): 51-9
- Harv Rev Psychiatry. 2009; (2): 138-46
- J Clin Endocrinol Metab. 2009; (8): 2922-9
- Med Hypotheses. 2009;
- Soc Psychiatry Psychiatr Epidemiol. 2009; (7): 515-22
- Acta Neurol Scand. 2009; (3): 172-9
- Arch Womens Ment Health. 2009;
- Neurochem Res. 2009; (2): 234-7
- Alzheimer Dis Assoc Disord. 2008 Jan-Mar; (1): 6-20
- Psychol Med. 2008; (7): 1069-71
- J Psychiatr Res. 2008; (3): 247-51
- Psychiatry Res. 2008; (1): 77-80
- Psychiatry Res. 2008; (3): 359-66
- Hum Reprod Update. 2007 Nov-Dec; (6): 607-16
- J Psychiatr Res. 2007 Apr-Jun; (3-4): 338-43
- Psychoneuroendocrinology. 2007; (3): 279-86
- J Affect Disord. 2007; (1-3): 227-33
- Curr Med Chem. 2007; (26): 2799-812
- J Neuropsychiatry Clin Neurosci. 2007; (2): 132-6
- J Clin Psychiatry. 2007; (12): 1989
- Bipolar Disord. 2006; (5 Pt 1): 424-9
- Drug Development Research. 2006; 150-159
- European Psychiatry. 2006; 262-269
- J Clin Psychopharmacol. 2006; (4): 361-6
- Int J Neurosci. 2006; (8): 895-906
- J Affect Disord. 2006; (1-2): 101-5
- Eur Psychiatry. 2006; (4): 262-9
- CNS Spectr. 2006; (5 Suppl 5): 1-16
- J Appl Clin Med Phys. 2006; (1): 86-96
- Bipolar Disord. 2006; (2): 160-7
- Am J Geriatr Psychiatry. 2006; (3): 293
- Journal of Nuclear Medicine. 2006; (S1): 300P
- Bipolar Case Review Quarterly. 2005; 3-6
- International Journal of Psychiatry in Clinical Practice.. 2005; (4): 251-256
- Psychiatry Res. 2005; (1): 73-80
- Mol Psychiatry. 2005; (5): 456-69
- J Magn Reson Imaging. 2005; (4): 398-405
- BJOG. 2005; (8): 1164
- J Geriatr Psychiatry Neurol. 2005; (4): 187-91
- MedGenMed. 2005; (3): 21
- CNS Spectr. 2005; (10): suppl14 1-15
- Neurobiol Aging. 2005; 103-7
- J Affect Disord. 2005; (1-3): 217-25
- J Psychiatr Res. 2005; (1): 77-83
- Neurobiol Aging. 2005; (2): 229-35
- Psychoneuroendocrinology. 2005; (6): 558-67
- Bipolar Disord. 2005; (3): 246-59
- CNS Spectr. 2005; (6): 471-8
- Psychoneuroendocrinology. 2005; (3): 284-96
- Bipolar Disord. 2004; (5): 435-9
- J Clin Psychopharmacol. 2004; (3): 322-34
- J Gerontol A Biol Sci Med Sci. 2004; (2): 178-83; discussion 184-92
- J Affect Disord. 2004; (2-3): 183-90
- J Gerontol A Biol Sci Med Sci. 2004; (10): 1076-7
- Arch Womens Ment Health. 2004; (3): 193-200
- Bipolar Disord. 2004; (1): 67-74
- Bipolar Disord. 2004; (1): 2-13
- Pharmacopsychiatry. 2003; S244-9
- Bipolar Disord. 2003; (1): 48-52
- CNS Spectr. 2003; (11): 805-14
- Pharmacopsychiatry. 2003; S215-21
- J Affect Disord. 2003; (3): 299-304
- Curr Drug Targets Immune Endocr Metabol Disord. 2002; (1): 97-102
- Curr Psychiatry Rep. 2002; (6): 419-28
- J Am Geriatr Soc. 2002; (11): 1826-30
- J Clin Psychiatry. 2002; 45-8
- Psychiatry Res. 2001; (1): 11-8
- Am J Psychiatry. 2001; (10): 1738
- Am J Geriatr Psychiatry. 2001; (4): 444-5
- Eur J Endocrinol. 2001; (1): 25-33
- Psychiatry Res. 2001; (1): 47-57
- J Clin Psychiatry. 2000; (12): 942-6
- J Clin Psychiatry. 2000; (3): 173-8
- Proc Natl Acad Sci U S A. 2000; (11): 6037-42
- Fertil Steril. 2000; (1): 144-9
- J Womens Health Gend Based Med. 1999; (9): 1141-6
- Harv Rev Psychiatry. 1998 Sep-Oct; (3): 121-32
- Can J Psychiatry. 1994; (7): 429-32
- Biull Eksp Biol Med. 1989; (11): 566-7
- Biull Eksp Biol Med. 1988; (12): 660-3
- Biull Eksp Biol Med. 1988; (2): 148-50
- Akush Ginekol (Mosk). 1987; (5): 67-9
- Akush Ginekol (Mosk). 1986; (11): 69-71